Maternal vitamin B12 deficiency and abnormal cell-free DNA results in pregnancy

Prenatal Diagnosis

Volumn 36, Issue 8, 2016, Pages 790-793

  Schuring Blom, Heleen ^a   Lichtenbelt, Klaske ^a   van Galen, Karin ^b   Elferink, Martin ^a   Weiss, Marjan ^c   Vermeesch, Joris Robert ^d   Page Christiaens, Lieve ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL FREE DNA; CHORIONIC GONADOTROPIN; CYANOCOBALAMIN; DNA; HAPTOGLOBIN; HEMOGLOBIN; INTRINSIC FACTOR ANTIBODY; LEVOTHYROXINE; PARIETAL CELL ANTIBODY; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; CASE REPORT; CYANOCOBALAMIN DEFICIENCY; DIATHERMIC EXCISION; FEMALE; GENETIC ANALYZER; GYNECOLOGIC SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; MACROCYTIC ANEMIA; MATERNAL DISEASE; MEAN CORPUSCULAR VOLUME; NON INVASIVE PRENATAL TESTING; NUCHAL TRANSLUCENCY MEASUREMENT; PERNICIOUS ANEMIA; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UTERINE CERVIX DYSPLASIA; VON WILLEBRAND DISEASE; Y CHROMOSOME;

EID: 84981200572     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4863     Document Type: Article

References (10)

1. Helgeson J, Wardrop J, Boomer T, et al. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015;35:1–6.
2. Amant F, Verheecke M, Wlodarska I, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol 2015;1(6):814–9.
3. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458–63.
4. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6(7):e21791.
5. Straver R, Sistermans EA, Holstege H, et al. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res 2014;42(5):341–350.
6. Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994;69(2):181–6.
7. Koury MJ, Price JO, Hicks GG. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism. Blood 2000;96:3249–55.
8. Ingram CF, Davidoff AN, Marais E, et al. Evaluation of DNA analysis for evidence of apoptosis in megaloblastic anaemia. Br J Haematol 1997;96:576–83.
9. Smulders YM, Smith DEC, Kok RM, et al. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol 2005;132:623–9.
10. Bianchi D. Prepare for unexpected prenatal test results. Women are learning about their own health problems through fetal screening. Nature 2015;522:29–30.